{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:14:45Z","timestamp":1769102085177,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clinthera.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:14:57Z","timestamp":1632924897000},"page":"1934-1947.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study"],"prefix":"10.1016","volume":"43","author":[{"given":"Massimo","family":"Cella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"T\u00e4ubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9016-3684","authenticated-orcid":false,"given":"Irisz","family":"Delestre-Levai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tulard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-2273","authenticated-orcid":false,"given":"George","family":"Georges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.09.001_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40413-016-0123-2","article-title":"Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document","volume":"9","author":"Braido","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.chest.2016.07.035","article-title":"on behalf of the Aerosol Drug Management Improvement Team (ADMIT). Dilemmas, confusion, and misconceptions related to small airways directed therapy","volume":"151","author":"Lavorini","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0003","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/07853890.2011.585656","article-title":"Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease","volume":"44","author":"Usmani","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0004","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(16)31354-X","article-title":"Single inhaler triple therapy versus inhaled corticosteroid plus long-acting \u03b22-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial","volume":"388","author":"Singh","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0006","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0007","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(17)30188-5","article-title":"Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial","volume":"389","author":"Vestbo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0008","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0009","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1177\/0091270004268128","article-title":"Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms","volume":"44","author":"Kim","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","article-title":"Molecular basis of ethnic differences in drug disposition and response","volume":"41","author":"Xie","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0011","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/js9702168","article-title":"Influence of race or ethnicity on pharmacokinetics of drugs","volume":"86","author":"Johnson","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cpt1974153267","article-title":"Absorption and metabolism of orally administered beclomethsone dipropionate","volume":"15","author":"Martin","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0013","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2222.1992.tb00175.x","article-title":"Long-acting \u03b22-agonists","volume":"22","author":"Tattersfield","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0014","first-page":"P118","article-title":"Biochemical and cardiovascular effects and urinary excretion of formoterol after single inhaled doses","volume":"80","author":"Bindschedler","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1399-6576.1989.tb02956.x","article-title":"Glycopyrrolate: pharmacokinetics and some pharmacodynamic findings","volume":"33","author":"Ali-Melkkil\u00e4","year":"1989","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0016","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.2042-7158.1974.tb09287.x","article-title":"The fate of intravenous [3H]glycopyrrolate in man","volume":"26","author":"Kaltiala","year":"1974","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0017","unstructured":"Japan Pharmaceuticals and Medical Devices Agency. Seebri Inhalation Capsules 50 Mcg: Reports on the Deliberation Results.; 2012. https:\/\/www.pmda.go.jp\/files\/000153897.pdf"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101976","article-title":"Ethnic pharmacokinetic comparison of budesonide\/glycopyrrolate\/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects","volume":"64","author":"Huang","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12890-020-01382-6","article-title":"Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects","volume":"21","author":"Inoue","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1211\/0022357991772439","article-title":"Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study","volume":"51","author":"Harrison","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/thoraxjnl-2011-200308","article-title":"Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: An 8-week, randomised, placebo-controlled trial","volume":"67","author":"Busse","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2021.09.001_bib0022","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF03259844","article-title":"Adverse reactions to \u03b22-agonist bronchodilators","volume":"1","author":"Lulich","year":"1986","journal-title":"Med Toxicol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:55:20Z","timestamp":1758963320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0149291821003532"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.09.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}